Merck is in the midst of a prolonged downtrend after hitting multiyear highs in 2012. Should you get in, or keep avoiding the Big Pharma stock? More
The Smaller They Are, the Harder They Fall (Sort of)
Small- and midcaps are unsurprisingly leading the market's march south, but micro- and nanocaps have proven resilient. That's still no reason to go diving into these tiny, risky companies. More
7 Biotechnology Stocks to Sell Now
This week, the overall grades of seven Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More
Disney Ship Earns Top 2013’s Cruise Rankings
The Disney Cruise Ship Disney Fantasy has won five of the 2013 Cruiser Awards from Cruise Critic. More
Forbes: Best Places to Retire in 2013
A new list compiles the 25 best places for seniors to retire this year. More
21 Commercial Banking Stocks to Buy Now
The grades of 21 Commercial Banking stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy"). More
Google Service Sings a New Tune
Google looks to take on big names like Apple and Pandora by launching a music-streaming service later this year. More
